T-cell subpopulations
were studied: CD70 expression depended both on the activating stimulus and on the T-cell subset analyzed. PMA + Ionomycin induced CD70 on the large majority of CD8 + cells, but only on a minority of CD4 + cells (P < 0.002). and among these. preferentially on the CD45RO+ subset compared with the CD45RA + The presence of CD4' lymphocytes in cell cultures containing mixtures of T-cell subsets inhibited CD70 expression on CD8 + cells. On the contrary, stimulation with allogeneic cells induced CD70 expression also on CD4+ cells. Moreover, CD70 was found to be expressed by chronically in vivo activated T-cells, in conditions characterized by allogeneic and autoimmune reactions. These data suggest a possible role of CD70 in the pdthogenesis of immune dysregukition; interestingly, this role may not be simply restricted to bind to. and signal through, CD27, since cross-linking of CD70 enhances the proliferative response induced by the stimuli used to elicit its expression. 6 1997 Elsevier Science B.V.
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Introduction
CD70, the ligand of CD27 [l-3] , is a member of the TNF family, a group of type II transmembrane proteins that. interacting with their counterreceptors, plays important roles in the regulation of activation, proliferation, differentiation and survival of a variety of cells [4, 5] .
In particular, CD27 ligation by CD70 amplifies T-cell [6] and B-cell [7] responses: CD70-transfected cells en-hance T-cell proliferation induced by suboptimal concentrations of PHA [1, 3, 8] and can cooperate with T-cell activation signals delivered by the CD80/CD28 system [9] , while a block of CD70-CD27 interactions with anti-CD70 mAb [lO,ll] CD70 is absent on resting lymphocytes but its expression can be induced on B and T-cells after in vitro activation [3, 10, . Information about expression of CD70 by different T-cell subpopulations, as well as about requirements and regulation of CD70 expression in normal and pathologic conditions are still incomplete.
In this study, we analyzed the expression of CD70 by purified T-cell subpopulations from healthy individuals and from patients with clinical conditions characterized by in vivo ongoing immune activation.
Materials and methods

Cell preparation
CD4 + or CD8 + cells were purified after Ficoll-Hypaque density gradient centrifugation, using positive selection with anti-CDC or anti-CD8-coated magnetic beads and Detach-a-beads (Dynal, Oslo, Norway), as described [ 161.
In some experiments, CD45RA + and CD45RO+ populations were further purified from CD4+ and CD8+ cells using negative selection with anti-mouse IgG-conjugated magnetic beads (Dynal) precoated for 30 min at 4°C with CD45RA (2H4; Coulter Immunology, Hialeah, FL) or CD45RO (UCHLl; BecktonDickinson, Mountain View, CA) mAbs; < 2% of negatively selected CD45RA+ or CD45RO+ population expressed the opposite CD45 isoform after this procedure.
Cell culture
PBMC, 2 x IO', or purified cells from preparations of T-cell subsets were cultured for various times at 37°C in 5% CO, in flat-bottomed microtitre plates in 200 ~1 of RPMI-1640-10% fetal calf serum (FCS) with or without different activating agents: PHA (1.2 pg/ml; Irvine Scientific, Santa Ana, CA): PMA (5 ng/ml; Sigma, St. Louis, MO) plus Ionomycin (500 ng/ml; Sigma);
Staphylococcus
Aureus Enterotoxin B and E (SEB, 500 ng/ml, SEE, 250 ng/ml; Serva Feinbiochemica, Heidelberg, Germany); 2 x 10s irradiated (2000r) allogeneic PBMC from a pool of healthy donors.
CD 70 expression
After activation, cells were washed twice with phosphate buffer saline (PBS)-5% FCS, incubated for 30 min at 4°C with 50 ~1 of the anti-human CD70 specific mAb 2F2 [l 11 . After washing, cells were incubated with fluorescine isothiocyanate (FITC)-conjugated goat antimouse IgG (Ortho, Raritan, NJ).
For double immunofluorescence analysis, biotin-conjugated anti-CD70 mAb (2F2) was used, followed by incubation with PE-conjugated Streptavidin (Sigma), in combination with FITC-conjugated mAbs.
In some experiments, the cells were incubated with PBS of various acid strength (down to pH 4.1) for 3 min at room temperature and washed twice with PBS pH 7.4, 5% FCS before staining for CD70 in order to dissociate possible soluble form of CD27 bound to CD70.
Flow cytometer analysis was carried out with an argon-ion laser equipped instrument (488 nm; Cytoron Absolute; Ortho), as described [16] . FITC-CD3, -CD4 and -CD8 mAbs were purchased from Ortho, PE-CD28 and -CD45RO from Beckton-Dickinson and PE-CD45RA from Coulter immunology.
CD70 mAb costimulation assuy
To assess costimulatory activity of CD70 mAb, flatbottomed microtitre plates were coated for 3 h at room temperature with 1:5000 dilution of either anti-human CD70 (2F2) or an isotype-matched control antibody (anti-human CD40, mAb 89, kindly provided by J. Bancherau, Dardilly, France) before the addition of T-cell populations and mitogenic stimuli. The CD70 mAb concentration was chosen as optimal for costimulation in preliminary experiments.
Cultures were labelled for the final 18 h with 1 pCi/well of [3H]Thymidine (Amersham, UK).
Statistical unalysis
Data are presented as mean f S.D. Wilcoxon's test was used to determine the significance of comparisons between means.
Results
CD 70 expression on normal T CD4 + und CDS+ cells
CD70
was absent in fresh peripheral blood lymphocytes from normal individuals. In particular, only 3.5 + 1.5% of purified CD4 + cells coexpressed CD70 (n = 7). As already reported [I3,15] , its expression could be induced on a proportion (35 + 13%) of PBMC by stimulation with PHA for 4 days. A similar level of CD70 expression (39 i 20%) was obtained by stimulating total PBMC with PMA + Ionomycin for 4 days.
The issue of the differential expression of CD70 by CD4+ and CD8 + T lymphocytes has been addressed in former studies analyzing by means of 2-color immunofluorescence bulk cultures of PBMC: no difference The in vitro expression of the molecule depended both on the stimulus utilized for activation and on the T-cell subset analyzed. Stimulation with PMA + Ionomycin led to CD70 expression only on a minority of purified CD4 + cells (12 + 6%, IZ = 9). as opposed to purified CD8 + cells (81 ? 7%, P < 0.002). A similar pattern was observed in four experiments in which stimulation with superantigens (SEB + SEE) was used: CD70 expression was detected on 29 + 10% of purified CD4 + cells, as opposed to 64 f 19% of CD8 + cells (P = 0.03). On the contrary, stimulation with allogeneic cells induced CD70 expression not only on CD8 + cells (85 f 6%). but also on CD4 + cells (73 + 10%; n = 3) (Fig. 1) .
In all cases, CD4 + or CD8 + lymphocytes were able to express other activation markers (CD69, CD25) at similar levels (data not shown), thus ruling out the possibility of a different sensitivity to the activating stimuli used.
CD70 expression is inhibited by the presence of CD4+ T lymphocytes in cell culture
The observation that the large majority of CD8 + cells acquires CD70 expression with all the activating agents studied when purified populations are cultured, whereas, if bulk cultures of PBMC are evaluated, only a minority of CD8 + cells becomes CD70 + , irrespective of the stimuli used ([10,15] (Fig. 2) .
A possibility to explain the inhibitory effect performed by CD4+ cells on CD70 expression is that this is masked by soluble CD27 (sCD27) able to bind CD70 [17, 18] , released by CD4 + cells after stimulation with PMA + Ionomycin.
To address this possibility, two sets of experiments were performed before staining for CD70: First, purified CD8 + cells were incubated for 1 h at 37°C with supernatant of PMA + lonomycin-stimulated purified CD4 + cells, in order to reproduce the inhibitory effect performed by CD4+ cells. Second, 
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Letters 55 (1997) purified CD4 + cells stimulated with PMA + Ionomycin were incubated for 3 min at room temperature with acid buffer (pH 4.1) in order to remove possible sCD27 bound to membrane CD70 (as described in the CD40L/ sCD40 system; [19] ). However, in neither experiments were we able to demonstrate an effect of sCD27 in reducing detection of CD70 molecule on activated cells (data not shown).
CD70 expression by different subsets of CD4+ or CD8+ lymphocytes separated according to the expression of different isoforms of CD45 antigen
Purified CD4+ or CD8 + were further divided into CD45RA+ and CD45RO+ by negative selection with magnetic beads and stimulated with PMA + Ionomycin as above. While no difference was observed among CDS+ subsets, CD70 was preferentially expressed by the CD4 + CD45RO + subset as compared to the CD4 + CD45RA + subset (47 + 26% vs. 21 + 12%; n = 5; P = 0.06).
CD70 is expressed by T-cells chronically activated in vi00
CD70 was expressed in vivo by CD4+ cells in conditions characterized by allogeneic reaction, such as engraftment of maternal T-cells in T-B ~ Severe Combined Immune Deficiency (two cases: 31 and 23%, respectively; Fig. 3) . In primary immunodeficiencies with residual circulating activated T-cells, as in Omenn's syndrome, a condition clinically resembling a Graft-Versus-Host reaction (five cases; Fig. 3 ) or combined immunodeficiency (four cases), expression of CD70 was observed on a large number of CD4+ cells (35 & 19%, P < 0.01 vs. healthy controls). In addition, CD70 was expressed also in the setting of autoimmune reactions by CD4 + lymphocytes isolated from synovial fluid from patients with rheumatoid (four cases; Fig. 3 ) or psoriatic (two cases; Fig. 3 ) arthritis (41 + 23%, P = 0.01 vs. controls).
In all cases, CD70+ cells expressed activation markers (CD25, HLA-DR) and were of 'memory' phenotype ( > 97% CD45RO+).
Crosslinking of CD 70 enhances T-cell prolij&ation
To assess the hypothesis that CD70 itself can transduce cellular activation signals, as suggested for other members of the TNF family [20-221, we investigated cmw38wDAoy: saDT9wmNATuwAL co4+cul.8 ENoMmmm CD4+ENOMmDCUU the proliferative capacity of purified T-cell populations exposed to stimuli able to induce CD70 expression on them. As shown in Fig. 4 One possible mechanism accounting for this phenomenon is the production of a soluble form of CD27 (sCD27), generated by proteolytic cleavage of the putative CD70-binding domain by activated T-cells [17, 18] . sCD27 released in the culture supernantant could mask the binding site of CD70 for the 2F2 mAb [l l] In analogy with what happens for CD40L, another molecule of the TNF family, rapidly down-modulated after contact with its receptor [24] , it can be suggested that CD70 down-modulation follows contact with CD27. The converse, i.e., CD27 down-modulation after CD27/CD70 interaction has already been clearly demonstrated [10, 15] .
vene in the amplification of the immune response, reducing the threshold for activation of CD4+ CD45RA + recruited in a 'second wave' of the response [6] , acting sinergically with the CD28 ligands, CD80/ CDS6 [9] . Since the signals delivered to CD4+ cells through the CD27 pathway are somehow qualitatively different from those acting through CD28 [9] , it has been suggested that this might also contribute to the diversification of the immune response.
On the other hand, allogeneic cells can induce CD70 expression on both CD4+ and CD8 + cells in vitro. This finding is accounted for by the recent demonstration of the important role played by APC-derived signals in the induction of CD70 expression on primed T-cells (Lens SM et al., in press ). The demonstration that in vivo, in conditions characterized by an allogeneic response or chronic immune activation, a large number of T lymphocytes (higher than that obtained in vitro by stimulation with mitogens on purified T-cells) express CD70 on the membrane of activated T lymphocytes provides support to data emerging from in vitro experiments, indicating the need for signals by APC in CD70 expression induction. Moreover, this observation suggests a relevant functional role of this molecule in the processes of lymphocyte activation and cell-to-cell communications. This role may not be simply restricted to bind to and signal through CD27 on other cell populations. In fact, we have shown that cross-linking of CD70 enhances the proliferative response induced by the stimuli used to elicit CD70 expression. Our results confirm preliminary observations [3] and demonstrate that CD70 itself can transduce activation signals. Interestingly, CD70 is associated with an undefined transmembrane protein, which can be the target of tyrosine phosphorylation [lo] . These data therefore suggest that the effects of the interactions between CD27 and CD70 should be analyzed in both directions. This couple of counterreceptors adds to others identified in recent years operating in the regulation of T-cell clonal expansion and effector function, whose interrelationships have just started to be studied for their possible implications in the pathogenesis of immune dysregulation [6, 15] .
